- Trials with a EudraCT protocol (120)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
120 result(s) found for: Perioperative period.
Displaying page 1 of 6.
EudraCT Number: 2017-000043-40 | Sponsor Protocol Number: GLOBE2017 | Start Date*: 2017-04-24 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: GLP-1 for bridging of hyperglycaemia during cardiac surgery: a randomized controlled trial | |||||||||||||
Medical condition: Hyperglyceamia during Cardiac Surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005136-76 | Sponsor Protocol Number: ASINC101C | Start Date*: 2005-05-02 |
Sponsor Name:Professor Christina Eintrei,Institution of Medical & Health, Section of Anesthesiology | ||
Full Title: Aspirin in noncardiac surgery | ||
Medical condition: Patients with cardiovascular risk factors undergoing elective non-cardiac surgery of high or intermediate risk. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001315-31 | Sponsor Protocol Number: GD032011 | Start Date*: 2011-09-21 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: analgesia with continuous IV-infusion of lidocain during the perioperative period in patients undergoin laparoscopic sterilization. | ||
Medical condition: postoperative pain | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001184-28 | Sponsor Protocol Number: PeP-RALP | Start Date*: 2022-10-11 |
Sponsor Name:Oslo University Hospital | ||
Full Title: Perioperative Propranolol in Robotic Assisted Laparoscopic Prostatectomy - A Pilot Study A parallel-group, phase 2, double-blind, 2-arm study to assess the feasibility of conducting a formal large... | ||
Medical condition: Prostate Cancer | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002725-23 | Sponsor Protocol Number: FPS-ROP-2021-03 | Start Date*: 2021-11-18 |
Sponsor Name:Fundación Pública Andaluza Progreso y Salud | ||
Full Title: ULTRASOUND-GUIDED ERECTOR SPINAE BLOCKADE AS PART OF MULTIMODAL ANALGESIA IN LUMBOSACRAL SURGERY: A PROSPECTIVE RANDOMISED STUDY. | ||
Medical condition: Pain in lumbosacral surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004552-37 | Sponsor Protocol Number: 18CH052 | Start Date*: 2019-05-07 | |||||||||||
Sponsor Name:CHU SAINT-ETIENNE | |||||||||||||
Full Title: Dose Study of Tranexamic Acid in Total Hip Replacement to Reduce Postoperative Hemoglobin Loss. A Phase 2 Randomized Double-blind Monocentric Study | |||||||||||||
Medical condition: Arthropathy of Hip | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003808-39 | Sponsor Protocol Number: MK-3475-866 | Start Date*: 2019-07-01 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC | |||||||||||||
Full Title: A Phase 3, Randomized Double Blind Study to Evaluate Peri-operative Pembrolizumab (MK-3475) + Neoadjuvant Chemotherapy versus Perioperative Placebo + Neoadjuvant Chemotherapy in Cisplatin-Eligible ... | |||||||||||||
Medical condition: Muscle Invasive Bladder Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) IE (Trial now transitioned) DE (Trial now transitioned) GB (GB - no longer in EU/EEA) DK (Trial now transitioned) BE (Trial now transitioned) HU (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003809-26 | Sponsor Protocol Number: MK-3475-905 | Start Date*: 2019-07-01 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC | |||||||||||||
Full Title: A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizumab versus Cystectomy Alone in Participants who ... | |||||||||||||
Medical condition: Muscle-invasive Bladder Cancer (MIBC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) GB (GB - no longer in EU/EEA) IE (Trial now transitioned) DK (Trial now transitioned) HU (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022417-25 | Sponsor Protocol Number: NL 33608 | Start Date*: 2011-04-18 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: Pheochromocytoma RandomisEd Study Comparing adRenoreceptor Inhibiting agents for Preoperative Treatment | |||||||||||||
Medical condition: Perioperative hemodynamic control in patients undergoing resection of a pheochromocytoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003595-11 | Sponsor Protocol Number: 2004-06-DP-119-RKF-25 | Start Date*: 2005-03-18 |
Sponsor Name:Canadian Cardiovascular Collaboration, Population Health Research Institute, McMaster University | ||
Full Title: PeriOperative ISchemic Evaluation study | ||
Medical condition: Perioperative cardiac events frequently complicate non-cardiac surgery resulting in significant morbidity, mortality and cost. There is no clear evidence from RCTs on how to lower perioperative ca... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003106-31 | Sponsor Protocol Number: MK-3475-B15 | Start Date*: 2021-04-27 | ||||||||||||||||
Sponsor Name:Merck Sharp & Dohme LLC | ||||||||||||||||||
Full Title: A Phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants wit... | ||||||||||||||||||
Medical condition: Urothelial Carcinoma and Muscle Invasive Bladder Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Trial now transitioned) FR (Trial now transitioned) PL (Trial now transitioned) CZ (Trial now transitioned) PT (Trial now transitioned) GR (Trial now transitioned) BG (Trial now transitioned) IT (Trial now transitioned) RO (Trial now transitioned) HU (Trial now transitioned) HR (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002023-15 | Sponsor Protocol Number: EFC16293 | Start Date*: 2020-02-25 | |||||||||||
Sponsor Name:Bioverativ Therapeutics Inc. (a Sanofi company) | |||||||||||||
Full Title: Phase 3 Open-Label, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (rFVIIIFc-VWF-XTE... | |||||||||||||
Medical condition: severe hemophilia A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) FR (Completed) BG (Completed) BE (Completed) GR (Completed) HU (Completed) NL (Completed) ES (Completed) Outside EU/EEA IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004733-14 | Sponsor Protocol Number: GSKET102011 | Start Date*: 2012-03-22 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: Intravenous S-Ketamine as an Analgesic Adjunct to General Anesthesia in chronic opioid-tolerant patient | ||
Medical condition: In the present investigation, we will compare the perioperative subanesthetic infusion of ketamine with placebo in opioid-resistant patients undergoing major orthopedic surgery. By powering the stu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2015-005521-39 | Sponsor Protocol Number: 241502 | Start Date*: 2016-06-20 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: A Phase 3, Multicenter, Single-arm, Open-label Study of the Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (BAX 802) in Subjects with Congenital Hemophilia A with Factor VI... | |||||||||||||
Medical condition: Congenital Haemophilia A with Factor VIII Inhibitors | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Prematurely Ended) NL (Prematurely Ended) PL (Prematurely Ended) DE (Prematurely Ended) NO (Prematurely Ended) BG (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020332-19 | Sponsor Protocol Number: Prot-22121988-2010 | Start Date*: 2010-08-23 | |||||||||||
Sponsor Name:ERASMUS MC, Dept Anesthesiology | |||||||||||||
Full Title: Putting Resistance under the Microscope. (Weerstand onder de Loep) | |||||||||||||
Medical condition: Patients resistance concerning diagnostic or therapeutic procedure are well known. In this trial patients-resistance during the perioperative period will be investigated in day-case-surgery. Feat... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013228-21 | Sponsor Protocol Number: | Start Date*: 2010-07-06 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: Prevention of atrial oxidative stress and electrical remodelling in patients undergoing cardiac surgery: randomised placebo-controlled trial of perioperative high-dose atorvastatin | |||||||||||||
Medical condition: POST-OPERATIVE ATRIAL FIBRILLATION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003795-39 | Sponsor Protocol Number: TKADEX | Start Date*: 2020-12-15 | |||||||||||
Sponsor Name:Turku University Hospital | |||||||||||||
Full Title: Premedication with intranasal dexmedetomidine in sedation of patients undergoing total knee arthroplasty (TKADEX) - a prospective, double blinded randomized controlled trial | |||||||||||||
Medical condition: Knee arthrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000769-18 | Sponsor Protocol Number: EFC16295 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Bioverativ Therapeutics Inc. | |||||||||||||
Full Title: A Phase 3 open-label, multicenter study of the safety, efficacy, and pharmacokinetics of intravenous recombinant coagulation Factor VIII Fc-von Willebrand Factor-XTEN fusion protein (rFVIIIFc-VWF-X... | |||||||||||||
Medical condition: Hemophilia A | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) IE (Completed) GB (GB - no longer in EU/EEA) BE (Completed) SE (Completed) HU (Completed) NL (Completed) IT (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001979-10 | Sponsor Protocol Number: ALMED-07-C3-007 | Start Date*: 2008-05-05 |
Sponsor Name:AIR LIQUIDE | ||
Full Title: AN INTERNATIONAL PHASE III RANDOMISED TRIAL COMPARING THE PROPOFOL CONSUMPTION DURING GENERAL ANAESTHESIA WITH XENON IN INSPIRATORY CONCENTRATIONS OF 50 % AND 70% AND TOTAL IV ANAESTHESIA ALONE I... | ||
Medical condition: general anaesthesia. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) DE (Completed) GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000265-20 | Sponsor Protocol Number: LM02 | Start Date*: 2012-06-06 |
Sponsor Name:ABCSG (Austrian Breast & Colorectal Cancer Study Group) | ||
Full Title: A perioperative, single-arm multicenter Phase II academic trial to investigate the efficacy and safety of panitumumab in combination with irinotecan/5-fluorouracil/leucovorin (FOLFIRI) in patients ... | ||
Medical condition: previously untreated, wild-type RAS, potentially resectable colorectal cancer liver metastases | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
